ClinVar Miner

Submissions for variant NM_004895.4(NLRP3):c.943A>G (p.Ile315Val) (rs180177501)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000521236 SCV000616679 uncertain significance not provided 2018-12-05 criteria provided, single submitter clinical testing The I315V variant in the NLRP3 gene has been reported previously, using alternate nomenclature I313V, in association with CAPS in a French family, however, familial segregation information and additional clinical information were not included (Cuisset et al., 2011). The I315V variant is observed in 18/66420 (0.03%) alleles from individuals of non-Finnish European background in the ExAC dataset (Lek et al., 2016). The I315V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved across species. However, I315V occurs in the NACHT domain, which is the major locus of CAPS-associated variants (Masters et al., 2009). In silico analysis predicts this variant likely does not alter the protein structure/function. We interpret I315V as a variant of uncertain significance.
Invitae RCV000525710 SCV000646279 uncertain significance Cryopyrin associated periodic syndrome 2017-08-21 criteria provided, single submitter clinical testing This sequence change replaces isoleucine with valine at codon 315 of the NLRP3 protein (p.Ile315Val). The isoleucine residue is moderately conserved and there is a small physicochemical difference between isoleucine and valine. This variant is present in population databases (rs180177501, ExAC 0.03%). This variant has been reported in three individuals affected with systemic auto-inflammatory disease (PMID: 26386126) and it has been reported to segregate with Cryopyrin-associated periodic syndromes in at least one family (PMID: 21109514). This variant is also known as p.Ile313Val in the literature. ClinVar contains an entry for this variant (Variation ID: 97989). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, this variant is a rare missense change with uncertain impact on splicing. Because it is found in the population at an appreciable frequency, this variant is not anticipated to cause disease. However, the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance.
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000825406 SCV000966703 uncertain significance not specified 2018-09-13 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Benign. The p.Ile315Val var iant in NLRP3 has been reported (as p.Ile313Val) in 1 individual with CAPS, and segregated with disease in at least 3 affected family members (Cuisset 2011). It was also reported in one individual with mevalonate kinase deficiency who carri ed additional variants in the MKV gene that were sufficient to explain their phe notype (Rusmini 2016). This variant has also been identified in 0.05% (58/126272 ) of European chromosomes by the Genome Aggregation Database (gnomAD; http://gno mad.broadinstitute.org/). Computational prediction tools and conservation analys is suggest that an isoleucine to valine change at position 315 may not impact th e protein, though this information is not predictive enough to rule out pathogen icity. On the other hand, additional computational tools suggest that this varia nt may create a novel splice site; however, this prediction may not reflect biol ogical function. In summary, while its frequency suggests that it is more likely to be benign, the clinical significance of the p.Ile315Val variant is uncertain due to the presence of conflicting data. ACMG/AMP Criteria applied: BS1, PP1.
Unité médicale des maladies autoinflammatoires, CHRU Montpellier RCV000084252 SCV000116388 not provided Familial cold urticaria no assertion provided not provided

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.